Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2004Journal of Viral Hepatitis

High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

SZSen ZhongShanghai Ninth People's HospitalWYWinnie YeoChinese University of Hong KongCSClaus H. SchröderGoethe University Frankfurt

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhong et al. (2004) studied this question.

synapsesocial.com/papers/6a9418b91e998d99dafee608https://doi.org/10.1046/j.1352-0504.2003.00467.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy2001 · 173 citations
  2. 2Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus–infected patients treated for non-Hodgkin lymphoma2002 · 74 citations
  3. 3Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study2003 · 206 citations
  4. 4Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies: Survey in Japan, 1987-19911996 · 173 citations
  5. 5Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non‐Hodgkin's lymphoma2002 · 91 citations